Literature DB >> 8610264

Breast cancer in young women.

D P Winchester1.   

Abstract

Breast cancer is an uncommon disease in women under the age of 40 years, reportedly accounting for 7.5% of reported cases. Delay in diagnosis is attributable to a clinically low index of suspicion, difficulty in examining dense and nodular breasts in younger women, and less frequently performed screening mammography. Genetic mutations should be suspected in women with breast cancer who are under the age of 30 years. In relation to older women, younger women have more adverse pathologic features and have a poorer prognosis. Younger age, per se, is not a contraindication to breast-conserving surgery. In node-negative young women, the benefits of adjuvant chemotherapy need to be considered in relation to the short- and long-term risks of treatment. A strong support system should be in place to deal with the adverse psychosocial impact of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8610264     DOI: 10.1016/s0039-6109(05)70439-4

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  12 in total

1.  A retrospective comparative study of clinicopathological features between young and elderly women with breast cancer.

Authors:  Qingli Zhang; Baohua Ma; Min Kang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Breast cancer under 40 years of age: increasing number and worse prognosis.

Authors:  Ágnes Dobi; Gyöngyi Kelemen; László Kaizer; Roland Weiczner; László Thurzó; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2010-09-17       Impact factor: 3.201

3.  Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials.

Authors:  Jos A van der Hage; J Sven D Mieog; Cornelis J H van de Velde; Hein Putter; Harry Bartelink; Marc J van de Vijver
Journal:  Breast Cancer Res       Date:  2011-06-24       Impact factor: 6.466

4.  Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.

Authors:  Volker Rudat; Hamdan El-Sweilmeen; Elias Fadel; Iris Brune-Erber; Alaa Ahmad Nour; Zinaida Bushnag; Nidal Masri; Saleh Altuwaijri
Journal:  J Oncol       Date:  2012-04-01       Impact factor: 4.375

Review 5.  Unique features of young age breast cancer and its management.

Authors:  Han-Byoel Lee; Wonshik Han
Journal:  J Breast Cancer       Date:  2014-12-26       Impact factor: 3.588

6.  Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts.

Authors:  Jingjing Wang; Jiayu Wang; Qing Li; Pin Zhang; Peng Yuan; Fei Ma; Yang Luo; Ruigang Cai; Ying Fan; Shanshan Chen; Qiao Li; Binghe Xu
Journal:  Oncotarget       Date:  2017-07-04

7.  Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population.

Authors:  Oscar J Manrique; Ali Charafeddine; Amjed Abu-Ghname; Joseph Banuelos; Steven R Jacobson; Jorys Martinez-Jorge; Minh-Doan Nguyen; Christin Harless; Nho V Tran; Basel Sharaf; James W Jakub; Tina J Hieken; Amy C Degnim; Judy C Boughey
Journal:  Medicina (Kaunas)       Date:  2019-08-14       Impact factor: 2.430

8.  Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?

Authors:  Aleyamma Mathew; Manoj Pandey; Balakrishnan Rajan
Journal:  World J Surg Oncol       Date:  2004-01-22       Impact factor: 2.754

9.  Young age: an independent risk factor for disease-free survival in women with operable breast cancer.

Authors:  Wonshik Han; Seok Won Kim; In Ae Park; Daehee Kang; Sung-Won Kim; Yeo-Kyu Youn; Seung Keun Oh; Kuk Jin Choe; Dong-Young Noh
Journal:  BMC Cancer       Date:  2004-11-17       Impact factor: 4.430

10.  Prognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expression.

Authors:  Jing He; Haijuan Wang; Fei Ma; Fengyi Feng; Chen Lin; Haili Qian
Journal:  Oncol Lett       Date:  2014-07-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.